DK643387D0 - T-celle-epitoper af hepatitis b-virus-nucleocapsid-protein - Google Patents

T-celle-epitoper af hepatitis b-virus-nucleocapsid-protein

Info

Publication number
DK643387D0
DK643387D0 DK643387A DK643387A DK643387D0 DK 643387 D0 DK643387 D0 DK 643387D0 DK 643387 A DK643387 A DK 643387A DK 643387 A DK643387 A DK 643387A DK 643387 D0 DK643387 D0 DK 643387D0
Authority
DK
Denmark
Prior art keywords
hepatitis
virus
cell epitopes
nucleocapside
protein
Prior art date
Application number
DK643387A
Other languages
English (en)
Other versions
DK643387A (da
Inventor
George B Thornton
Ann M Moriarty
David R Milich
Alan Mclachlan
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/939,617 external-priority patent/US4818527A/en
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK643387D0 publication Critical patent/DK643387D0/da
Publication of DK643387A publication Critical patent/DK643387A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/223—Hepatitis related

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK643387A 1986-12-09 1987-12-08 T-celle-epitoper af hepatitis b-virus-nucleocapsid-protein DK643387A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/939,617 US4818527A (en) 1986-12-09 1986-12-09 T cell epitopes of the hepatitis B virus nucleocapsid protein
US07/106,538 US4882145A (en) 1986-12-09 1987-10-07 T cell epitopes of the hepatitis B virus nucleocapsid protein

Publications (2)

Publication Number Publication Date
DK643387D0 true DK643387D0 (da) 1987-12-08
DK643387A DK643387A (da) 1988-06-10

Family

ID=26803781

Family Applications (1)

Application Number Title Priority Date Filing Date
DK643387A DK643387A (da) 1986-12-09 1987-12-08 T-celle-epitoper af hepatitis b-virus-nucleocapsid-protein

Country Status (7)

Country Link
US (1) US4882145A (da)
EP (1) EP0271302A3 (da)
JP (1) JPS6425800A (da)
AU (1) AU618942B2 (da)
CA (1) CA1329766C (da)
DK (1) DK643387A (da)
PT (1) PT86318B (da)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143726A (en) * 1986-12-09 1992-09-01 The Scripps Research Institute T cell epitopes of the hepatitis B virus nucleocapsid protein
DE10299017I2 (de) * 1987-06-22 2005-05-25 Medeva Holdings Bv Hepatitis-B-Oberfl{chenantigen enthaltendes Peptid.
AU608354B2 (en) * 1987-07-30 1991-03-28 Wistar Institute, The Vaccination against rabies-related viruses
US6130082A (en) * 1988-05-05 2000-10-10 American Cyanamid Company Recombinant flagellin vaccines
GB8903313D0 (en) * 1989-02-14 1989-04-05 Wellcome Found Conjugates
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
PT97632A (pt) * 1990-05-11 1992-03-31 Scripps Clinic Res Processo de obtencao de polipeptidos relacionados com a proteina do antigenio de superficie do virus da hepatite b e de vacinas que os contem
IE912535A1 (en) * 1990-07-27 1992-01-29 Res Dev Foundation Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
GB9016727D0 (en) * 1990-07-31 1990-09-12 Clonit Spa Amino acid residue sequence of hepatitis b core antigen
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
AU9052091A (en) * 1990-12-20 1992-07-22 Smithkline Beecham Biologicals (Sa) Vaccines based on hepatitis b surface antigen
FR2671554A1 (fr) * 1991-01-11 1992-07-17 Clonatec Sa Peptides synthetiques derivant de l'antigene hbc du virus de l'hepatite b, leurs applications a la detection d'une infection par ce virus et a la vaccination contre l'hepatite b.
US5175094A (en) * 1991-08-01 1992-12-29 Becton Dickinson And Company Increased expression of HBcAg
US5175272A (en) * 1991-08-01 1992-12-29 Becton Dickinson And Company DNA sequences with increased expression of HBcAg
US5173427A (en) * 1991-08-01 1992-12-22 Becton Dickinson And Company Vectors and hosts with increased expression of HBCAG
US5780036A (en) * 1991-08-26 1998-07-14 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus
WO1993003764A1 (en) * 1991-08-26 1993-03-04 Cytel Corporation Hla-restricted hepatitis b virus ctl epitopes
EP0534618B1 (en) * 1991-08-26 2006-03-15 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
US6607727B1 (en) * 1991-08-26 2003-08-19 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus
US6322789B1 (en) 1991-08-26 2001-11-27 Epimmune, Inc. HLA-restricted hepatitis B virus CTL epitopes
US6419931B1 (en) 1991-08-26 2002-07-16 Epimmune Inc. Compositions and methods for eliciting CTL immunity
US5939524A (en) * 1991-12-09 1999-08-17 The Scripps Research Institute Platelet GPIII P1A1 and P1A2 epitopes, their preparation and use
CN1065142C (zh) * 1992-01-14 2001-05-02 麦迪瓦赫丁公司 组合物用作慢性病毒性肝脏疾病治疗剂的应用
US7611713B2 (en) * 1993-03-05 2009-11-03 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide compositions
US6689363B1 (en) 1992-01-29 2004-02-10 Epimmune Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
US20110097352A9 (en) * 1992-01-29 2011-04-28 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
US6235288B1 (en) 1992-08-26 2001-05-22 The Scripps Research Institute Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
JPH08502062A (ja) * 1992-09-30 1996-03-05 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデーション ワクチンおよび抗原結合体
CA2151044A1 (en) * 1992-12-15 1994-06-23 Terence K. Brunck Novel inhibitors for factor xa
US5399667A (en) * 1993-03-05 1995-03-21 Washington University Thrombospondin receptor binding peptides
US5709995A (en) * 1994-03-17 1998-01-20 The Scripps Research Institute Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
US20020136733A1 (en) * 1994-03-31 2002-09-26 Hill Adrian Vivian Sinton Malaria peptides
AU2540897A (en) * 1996-03-21 1997-10-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods and compositions of chimeric polypeptides for tumor antigen vaccines
WO1998012332A1 (en) 1996-09-17 1998-03-26 Chiron Corporation Compositions and methods for treating intracellular diseases
CN1063756C (zh) * 1997-10-06 2001-03-28 中国科学院上海生物化学研究所 同时含有乙肝病毒和丙肝病毒核心抗原的双重抗原
AU767144B2 (en) * 1998-02-12 2003-10-30 Apovia, Inc. Strategically modified hepatitis B core proteins and their derivatives
US7105164B1 (en) * 1998-04-07 2006-09-12 Sanofi Pasteur Limited HIV-specific cytotoxic T-cell responses
CU22871A1 (es) * 1998-12-02 2003-10-21 Ct Ingenieria Genetica Biotech Formulaciones conteniendo partículas semejantes a virus como inmunopotenciadores por vía mucosal
CA2352738A1 (en) 1998-12-04 2000-06-08 Biogen, Inc. Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
US6887464B1 (en) * 1999-02-02 2005-05-03 Biocache Pharmaceuticals, Inc. Advanced antigen presentation platform
CA2419046C (en) * 2000-08-11 2007-10-02 Advanced Life Science Institute, Inc. Method for detecting or measuring hbv
US20030138769A1 (en) * 2000-08-16 2003-07-24 Birkett Ashley J. Immunogenic HBc chimer particles having enhanced stability
US6942866B2 (en) 2000-08-16 2005-09-13 Apovia, Inc. Malaria immunogen and vaccine
ATE354662T1 (de) * 2001-03-23 2007-03-15 Deutsches Krebsforsch Modifizierte hpv e6- und e7-gene und -proteine als impfstoff
US7361352B2 (en) 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
US20030037327A1 (en) * 2001-08-15 2003-02-20 International Business Machines Corporation Run-time rule-based topological installation suite
US20030175863A1 (en) * 2001-08-15 2003-09-18 Birkett Ashley J. Influenza immunogen and vaccine
US20030185858A1 (en) * 2001-08-15 2003-10-02 Birkett Ashley J. Immunogenic HBc chimer particles stabilized with an N-terminal cysteine
US7351413B2 (en) * 2002-02-21 2008-04-01 Lorantis, Limited Stabilized HBc chimer particles as immunogens for chronic hepatitis
US7144712B2 (en) * 2003-07-30 2006-12-05 Vaccine Research Institute Of San Diego Human hepatitis B virus core proteins as vaccine platforms and methods of use thereof
AU2004260665B2 (en) 2003-07-30 2007-11-15 Vlp Biotech, Inc. Hepatitis virus core proteins as vaccine platforms and methods of use thereof
US7320795B2 (en) * 2003-07-30 2008-01-22 Vaccine Research Institute Of San Diego Rodent hepatitis B virus core proteins as vaccine platforms and methods of use thereof
AU2005248361B2 (en) 2004-05-18 2010-03-11 Vical Incorporated Influenza virus vaccine composition and methods of use
US8163880B2 (en) 2006-02-23 2012-04-24 Era Biotech S.A. Production of biologically active proteins
KR20110084906A (ko) 2008-10-10 2011-07-26 에라 바이오테크, 에스.에이. 면역원-특이적 면역보강제로서의 재조합 단백질체들
EP2391383B1 (en) 2009-02-02 2015-12-23 ChronTech Pharma AB Codon-optimized hepatitis b virus core antigen (hbcag)
EP2418284A1 (en) 2010-08-13 2012-02-15 ERA Biotech, S.A. Protein body-inducing polypeptide sequences
US20160324954A1 (en) 2013-05-15 2016-11-10 Chrontech Pharma Ab Immunogenic compositions for inhibiting hepatitis d virus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61904A (en) * 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
US4663436A (en) * 1984-04-24 1987-05-05 Scripps Clinic And Research Foundation Leukemia-associated virus immunogen, vaccine and assay
US4584195A (en) * 1984-06-21 1986-04-22 The Board Of Trustees Of The Leland Stanford Junior University Broad spectrum vaccine against gonorrhea
US4683136A (en) * 1985-03-06 1987-07-28 Scripps Clinic And Research Foundation Proteinaceous antigens with conformation-independent and conformation-dependent determinants

Also Published As

Publication number Publication date
PT86318B (pt) 1990-11-07
AU618942B2 (en) 1992-01-16
EP0271302A3 (en) 1989-03-15
DK643387A (da) 1988-06-10
JPS6425800A (en) 1989-01-27
US4882145A (en) 1989-11-21
CA1329766C (en) 1994-05-24
EP0271302A2 (en) 1988-06-15
PT86318A (en) 1988-01-01
AU8223187A (en) 1988-06-09

Similar Documents

Publication Publication Date Title
DK643387D0 (da) T-celle-epitoper af hepatitis b-virus-nucleocapsid-protein
DK156688A (da) Praeparat til behandling af virusinfektioner
DK603888D0 (da) Rekombinant virus
FI940918A0 (fi) Hepatiitti B-viruksen HLA-rajoitetut CTL-epitoopit
DK213987A (da) Hepatitis b-peptidimmunogen
DK174887D0 (da) Forbedring af polymerisationslivlighed ved anvendelse af silylerede oxyanioner
FR2620459B1 (fr) Virus recombinant de la vaccine
DK110289D0 (da) Fremgangsmaade til fremstilling af cycliske sulfater
DK363887A (da) Anvendelse af bromcruptin
DK417887A (da) Sekretion af heterologe proteiner fra gaer
DK121591A (da) Fremgangsmaade til fremstilling af gelatinefolier
DK85589D0 (da) Ekspression af hiv-bindende proteiner
DK88988D0 (da) T- og b-celleepitoper af pre-s-regionen af hepatitis-b-virus-overfladeantigen
DK549688A (da) Fremstilling af peptider
DK185988D0 (da) Anvendelse af antigen
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
ITRM910546A0 (it) Epitopi della proteina env del virus dell'epatite c
DK606587D0 (da) Immunbestemmelse af koncentration ved mebranaffinitet
DK541487D0 (da) Sammenfoejning af materialer
DK135387D0 (da) Fremstilling af proteiner
DK175587D0 (da) Fremstilling af substituerede (dichlormethyl)-pyridiner
DK321986A (da) Fremstilling af proteiner
KR880700674A (ko) 위 광견병 비루스 왁찐
DK460987D0 (da) Fremstilling af proteiner.
DK697188A (da) Fremgangsmaade til detektering af antistof mod hiv (human immunodeficiency virus)

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment